Frontier Medicines Corporation, based in South San Francisco, CA, is a pioneering biotechnology company that is boldly advancing science to defeat disease. With their proprietary platform powered by chemoproteomics, covalent chemistry, and machine learning, they are unlocking the proteome to develop breakthrough medicines for patients, targeting otherwise undruggable disease-causing targets.
By integrating cutting-edge technologies such as machine learning, context-dependent screening, and rigorous biophysical and analytical methods, Frontier Medicines is focused on developing precision medicines for genetically-defined patient populations, aiming to deliver maximal benefit. Their quest to explore new frontiers in medicine is driving their mission to revolutionize the treatment of diseases.
Generated from the website